Ticagrelor
Showing 1 - 25 of 654
Ticagrelor Trial (Ticagrelor 60mg)
Not yet recruiting
- Ticagrelor
- Ticagrelor 60mg
- (no location specified)
Apr 25, 2023
Ischemic Stroke Trial in Kafr Ash Shaykh (Ticagrelor 90 MG, Clopidogrel)
Recruiting
- Ischemic Stroke
- Ticagrelor 90 MG
- Clopidogrel
-
Kafr Ash Shaykh, EgyptKafr Elsheikh University Hospital
Nov 7, 2023
Intracranial Aneurysm, Stent Complication Trial (Ticagrelor monotherapy, Dual Antiplatelet Therapy)
Not yet recruiting
- Intracranial Aneurysm
- Stent Complication
- Ticagrelor monotherapy
- Dual Antiplatelet Therapy
- (no location specified)
Aug 23, 2023
Stable Chronic Angina Trial in Shiraz (Clopidogrel, Ticagrelor)
Completed
- Stable Chronic Angina
- Clopidogrel
- Ticagrelor
-
Shiraz, Iran, Islamic Republic ofProfessor Kojuri Cardiology Clinic
May 12, 2023
ADHerence of ticagrelOr in Real World aCute Coronary Syndrome
Completed
- Acute Coronary Syndrome
- Ticagrelor
- (no location specified)
Jan 10, 2023
ST Elevation Myocardial Infarction Trial in Netherlands (Ticagrelor, Aspirin)
Recruiting
- ST Elevation Myocardial Infarction
- Ticagrelor
- Aspirin
-
Alkmaar, Netherlands
- +4 more
Aug 3, 2023
Coronary Heart Disease Trial in Beijing (Ticagrelor, Clopidogrel, Aspirin)
Not yet recruiting
- Coronary Heart Disease
- Ticagrelor
- +2 more
-
Beijing, Beijing, ChinaFuwai Hospital
Oct 15, 2023
Ticagrelor Versus Clopidogrel for CMD in AMI: A Retrospective
Completed
- Coronary Heart Disease
- Dual antiplatelet therapy with aspirin and either ticagrelor or clopidogrel
-
Hangzhou, Zhejiang, ChinaSecond affiliated Hospital Zhejiang University School of Medicin
Jul 31, 2023
Healthy Individuals Trial in Karachi (Anplag (Ticagrelor 90 mg), Brilinta (Ticagrelor 90 mg))
Completed
- Healthy Individuals
- Anplag (Ticagrelor 90 mg)
- Brilinta (Ticagrelor 90 mg)
-
Karachi, Sindh, PakistanCenter for Bioequivalence Studies and clinical research
Sep 5, 2022
Acute Coronary Syndrome, STEMI, NSTEMI Trial in Naples (Ticagrelor 90mg, Ticagrelor 60 mg)
Completed
- Acute Coronary Syndrome
- +4 more
- Ticagrelor 90mg
- Ticagrelor 60 mg
-
Naples, ItalyProfessor Giovanni Esposito
Jul 6, 2022
Non ST Segment Elevation Acute Coronary Syndrome, Non-ST-Segment Elevation Myocardial Infarction (NSTEMI), Unstable Angina Trial
Not yet recruiting
- Non ST Segment Elevation Acute Coronary Syndrome
- +2 more
- De-escalation to ticagrelor 60 mg at day 30
- +3 more
-
Bydgoszcz, Kujawsko-pomorskie, PolandDepartment of Cardiology, Dr. A. Jurasz University Hospital, Col
Mar 9, 2023
Senior Acute Coronary Syndrome Patients After PCI Trial in Shanghai (Ticagrelor)
Recruiting
- Senior Acute Coronary Syndrome Patients After PCI
- Ticagrelor
-
Shanghai, Shanghai, Chinashanghai Tongren hospital
Dec 19, 2022
Individualized and Combined Effects of Smoking and Diabetes on the Antiplatelet Activity in Patients Undergoing Primary
Recruiting
- Individualized and Combined Effects of Smoking and Diabetes on the Antiplatelet Activity in Patients Undergoing Primary Percutaneous Coronary Intervention
- Ticagrelor
-
Cairo, EgyptFaculty of medicine of girls, Cardiology department, Al-Azhar Un
Jun 10, 2023
Atrial Fibrillation, Acute Coronary Syndrome Trial in Ottawa (Ticagrelor, Rivaroxaban)
Active, not recruiting
- Atrial Fibrillation
- Acute Coronary Syndrome
- Ticagrelor
- Rivaroxaban
-
Ottawa, Ontario, CanadaUniversity of Ottawa Heart Institute
Jan 12, 2023
Ischemic Stroke Trial in Kafr Ash Shaykh (Ticagrelor 90 MG Oral Tablet, Clopidogrel tablet)
Recruiting
- Ischemic Stroke
- Ticagrelor 90 MG Oral Tablet
- Clopidogrel tablet
-
Kafr Ash Shaykh, EgyptKafr Elsheikh University Hospital
Nov 18, 2022
Acute Coronary Syndrome, Coronary Stent Implantation Trial in China (Ticagrelor 60mg, Ticagrelor 90mg)
Recruiting
- Acute Coronary Syndrome
- Coronary Stent Implantation
- Ticagrelor 60mg
- Ticagrelor 90mg
-
Taishan, Guangdong, China
- +6 more
Dec 19, 2022
Acute Coronary Syndrome, Percutaneous Coronary Intervention Trial in Hangzhou (Standard-DAPT of Ticagrelor plus aspirin,
Not yet recruiting
- Acute Coronary Syndrome
- Percutaneous Coronary Intervention
- Standard-DAPT of Ticagrelor plus aspirin
- Sequential monotherapy of Ticagrelor and clopidogrel
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine at Zhejiang Universi
Sep 20, 2022
Coronary Artery Disease Trial in Aalst (Ticagrelor, Prasugrel)
Completed
- Coronary Artery Disease
- Ticagrelor
- Prasugrel
-
Aalst, BelgiumAalst cardiovascular center
Nov 30, 2022
Adverse Reactions of Ticagrelor on Ischemic Cerebrovascular
Not yet recruiting
- Cerebral Infarction
- +3 more
- (no location specified)
Jan 29, 2023
Disparities in Proportion of Ticagrelor and Prasugrel-eligible
Not yet recruiting
- Acute Myocardial Infarction
- There was no intervention necessary.
-
Heidelberg, Baden-Württemberg, GermanyUniversity Hospital of Heidelberg
Mar 19, 2023
Chronic Coronary Disease Trial in Worldwide (Ticagrelor 90 MG, Ticagrelor )
Not yet recruiting
- Chronic Coronary Disease
- Ticagrelor 90 MG
- Ticagrelor placebo
-
New York, New York
- +11 more
Aug 11, 2023
Acute Coronary Syndrome Patients With Diabetes After PCI Trial in Shanghai (Ticagrelor, Aspirin)
Recruiting
- Acute Coronary Syndrome Patients With Diabetes After PCI
- Ticagrelor
- Aspirin
-
Shanghai, Chinashanghai Tongren hospital
Aug 31, 2022
Antiplatelet Drug, Acute Coronary Syndrome, Angioplasty, Balloon Trial in Xi'an (Aspirin 100mg for 1-month (immediately after
Recruiting
- Antiplatelet Drug
- +2 more
- Aspirin 100mg for 1-month (immediately after PCI)
- +4 more
-
Xi'an, Shannxi, ChinaLing Tao
Jul 20, 2022
Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome Trial in Seoul
Completed
- Coronary Artery Disease
- +2 more
-
Seoul, Korea, Republic ofYoung-Hyo Lim
Feb 24, 2023
Acute Myocardial Infarction Trial in Gothenburg (Ticagrelor 90mg)
Recruiting
- Acute Myocardial Infarction
- Ticagrelor 90mg
-
Gothenburg, SwedenKardiologen
Jun 7, 2022